DMAA
Drugs Made In America Acquisition Corp
DMAA
DMAA
32 hedge funds and large institutions have $212M invested in Drugs Made In America Acquisition Corp in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
3.34% more ownership
Funds ownership: 58.79% → 62.13% (+3.3%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.04M | |
| 2 | +$7.04M | |
| 3 | +$6.63M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$5.81M |
| 5 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$4.28M |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$6.51M | |
| 3 | -$1.65M | |
| 4 |
CA
Crossingbridge Advisors
Pleasantville,
New York
|
-$1.3M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$518K |
